Biotech is blooming in Italy

Biotech is blooming in Italy

Italy is blooming in biotech, with a slew of initiatives growing from seed stage to series A. The environment has evolved, public awareness has been raised and in the last 5 years new VC players, Corporate VCs and public initiatives have emerged extracting value from Italian quality science. Much remains to be done for the first exits, but it is the right time for local and international investors to scout and invest in promising assets. Thank you, Biotech Finances, for your contribution to shed light on this geography and its environment. #biotech #venturecapital #pharmaceuticals

Alessio Beverina, Paolo Di Giorgio, Pietro Puglisi, Pierluigi Paracchi, Ciro Spedaliere, Paolo Fundarò, Federica Draghi, Daniele Scarinci, Davide Turco, Elizabeth Robinson, Giovanni Rizzo, Giancarlo Rocchietti, Graziano Seghezzi, Lucia Faccio, Paola Pozzi, Francesco Cerruti, Claudia Pingue, Thomas Hanke, Alain Huriez, Geoffroy De Ribains, Thierry Laugel, 🧪 Ward Capoen, Katja Rosenkranz, Bruno Montanari, Daniel O'Mahony, Laura Soucek, Daniela Bellomo, Guido Guidi, Gabriele Campi, PhD, Paolo Rizzardi Davide Santi, Marianne Bjørdal, Stefano Coco, CDP Venture Capital SGR, Jacques-Bernard Taste, Marie Albessard

José Luis Cabero

Passion and experience to impulse and support entrepreneurship in life sciences | Advisor

1y

Congratulations Edoardo and colleagues for this good article!

Arnaud Peyronnier

INOVOTION: Unique In Vivo Model in Oncology & Immuno-Oncology for Biotech, Pharma and Academic Labs | Preclinical boost!

1y

To view or add a comment, sign in

Insights from the community

Others also viewed

Explore topics